Jan 17, 2017 13:30 pm UTC| Business
PASADENA, Calif., Jan. 17, 2017 -- General Finance Corporation (NASDAQ:GFN), a leading specialty rental services company offering portable storage, modular space and liquid containment solutions (the “Company”),...
Former HP Executive Joins Mimecast to Drive Global Channel Sales
Jan 17, 2017 13:30 pm UTC| Business
Watertown, MA, Jan. 17, 2017 -- Mimecast Limited (NASDAQ: MIME), a leading email and data security company, today announced Eli Kalil joins the leadership team as the new Senior Vice President of Global Channel Sales....
Jonah Shacknai Joins Obalon Therapeutics, Inc. Board of Directors
Jan 17, 2017 13:27 pm UTC| Business
SAN DIEGO, Jan. 17, 2017 -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Jonah Shacknai, Executive Chairman of DermaForce and former Chairman and Chief...
ChinaNet Online Holdings Announces Updated Corporate Website
Jan 17, 2017 13:19 pm UTC| Business
BEIJING, Jan. 17, 2017 -- ChinaNet Online Holdings, Inc. (Nasdaq:CNET) ("ChinaNet" or the "Company"), an integrated data-analysis and management services platform, today announced the official launch of its updated...
Laredo Petroleum Announces 2017 Capital Budget of $530 Million
Jan 17, 2017 13:06 pm UTC| Business
TULSA, OK, Jan. 17, 2017 -- Laredo Petroleum, Inc. (NYSE:LPI) (“Laredo” or “the Company”) announces its 2017 capital budget and anticipated production growth and its conference call to discuss fourth-quarter and...
Tesaro Announces Opening of Niraparib Expanded Access Program for U.S. Patients With Ovarian Cancer
Jan 17, 2017 13:03 pm UTC| Business
WALTHAM, Mass., Jan. 17, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the opening of an expanded access program (EAP) in the United States for the investigational...
Tesaro Announces Opening of Niraparib Expanded Access Program for U.S. Patients With Ovarian Cancer
Jan 17, 2017 13:03 pm UTC| Business
WALTHAM, Mass., Jan. 17, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the opening of an expanded access program (EAP) in the United States for the investigational...